all B3 and B4
-- http://www.abstracts2view.com/hem07/view.php?nu=HEM07L1_5438.
The following abstract will be presented in an oral session on red cell
regulation and disorders of production on Tuesday, December 11, 2007. The
abstract and presentation information can be accessed at the link provided
below.
-- Publication Number 840: "Significant Disease Burden in Paroxysmal
Nocturnal Hemoglobinuria Patients with Lower Levels of Hemolysis,
Mild Anemia and Minimal Transfusion: Clinical Improvement with
Eculizumab Therapy" Dr. Monica Bessler et al.
-- Location: Rooms B213-B214
-- Tuesday, December 11, 2007 - 8:45 a.m.
-- http://www.abstracts2view.com/hem07/view.php?nu=HEM07L1_5302.
'/>"/>SOURCE Alexion Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast2.
Alexion to Present at Investor Conferences3.
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference4.
Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet5.
Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum6.
Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma7.
Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences8.
Vista Partners Updates Coverage on Tapestry Pharmaceuticals9.
Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference10.
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.11.
Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes